|
UP TO DATE STUDIES ON NUTRITION AND THE EYE
MACULAR
DEGENERATION STUDIES
1.
Risk of developing advanced disease was reduced by about 25% in
those with intermediate damage from taking 500 mg of vitamin C,
15 mg of beta carotene, 400 IU of vitamin E and 80 mg of zinc on
a daily basis.
2.
A preliminary study showed those consuming lutein from either spinach
or supplements demonstrated improvement of some of the early vision
loss from "dry" macular degeneration.
3.
Consuming 6 mg of the caroteinoid lutein (w/ it's co-nutrient zeaxanthin)
daily for five months was shown to significantly increase macular
pigment density, which protects from harmful blue wavelength light
believed to be most responsible for macular degeneration.
4.
High macular pigment density was associated with the retention of
youthful visual sensitivity, which suggested that increasing macular
pigment may retard age-related declines in visual function.
5.
Persons who had the lowest serum levels of lycopene, the most abundant
carotenoid in the serum, were twice as likely to have macular degeneration
when compared to those with the highest levels.
6.
Those consuming lutein rich foods (spinach and collard greens) five
days per week were 8 times less likely to develop macular degeneration
as those consuming them once per month.
7.
The ARMD population manifested decreased intake of vitamin E, magnesium,
zinc, vitamin B6 and folic acid. Patients with advanced ARMD taking
antioxidants twice daily maintained vision in their better functioning
eyes significantly better than those taking a placebo.
8.
Smokers with early macular degeneration who consumed the lowest
amounts of carotenoids were nearly 6X as likely to develop advanced
macular degeneration than those consuming the highest amounts.
9.
In a clinical trial 60% of subjects with ARMD or diabetic macular
edema who received 500 mg of vitamin C, 400 IU of vitamin E, 15,000
IU of beta carotene and selenium showed either improvement or no
further progression of their disease. So Med J, 1987.
10.
The evidence suggests that carotenoids and antioxidant vitamins
may help to retard some of the destructive processes in the retina
and the retinal pigment epithelium which are responsible for age-related
degeneration of the macula.
11.
The minerals copper and zinc are required to synthesize superoxide
dismutase and other enzymes in the retina which scavenge free radicals,
preventing the oxidative damage which plays a role in the development
of drusen, an early sign of Age-Related Macular Degeneration.
12.
Glutathione and its related enzyme precursor amino acids (N-Acetyl-Cysteine,
L-glycine, and glutamine and selenium) are protective against damage
to human retinal pigment epithelium cells.
13.
Quercetin protected bovine retinas in vitro from induced lipid peroxidation,
especially when combined with vitamin E, suggesting a potential
protective effect in age-related macular degeneration.
14.
Deficiency of taurine, an amino acid, has been shown to lead to
retinal degeneration and supplementing it has been used with some
success to prevent, treat and stabilize retinal changes.
15.
After 18 months, subjects with macular degeneration who took antioxidants
on a consistent basis were 2.5X more likely to improve on visual
acuity testing, and four times less likely to deteriorate in their
worst eye, compared to those who took them less consistently.
16.
Patients with confluent soft drusen, or "pre-wet" ARMD, were found
to have evidence of vitamin B6 deficiency. B. Lane, Ann Mtg Amer
Coll of Nutrition, 1991.
17.
General measures for prevention and remediation of macular degeneration
would include a combination of supplementation with trace elements,
antioxidants and other vitamins, ...increasing physical fitness,
improving nutrition (e.g. avoiding hydrogenated oils), abstaining
from smoking, and protection from excessive light exposure.
18.
There is an association between both low serum selenium levels and
current smoking status and the development of age-related macular
degeneration.
19.
There was an inverse relationship between dietary pro-vitamin A
carotenoid and vitamin E consumption and the incidence of large
macular drusen, as well as between zinc levels and the incidence
of retinal pigment abnormalities.
20.
The evidence suggests that carotenoids and antioxidant vitamins
may help to retard some of the destructive processes in the retina
and the retinal pigment epithelium that lead to age-related degeneration
of the macula.
21.
Subnormal zinc and/or vitamin E serum levels may be associated with
as much as an 82% increased risk of advanced age-related macular
degeneration. Vitamin C and lipoic acid help to recycle vitamin
E in the retinal tissues.
22.
In a study of adults over 60 there was found to be a significant
link between risk of macular degeneration and low blood levels of
vitamin E as well as increased sun exposure.
23.
A statistically significant improvement in visual acuity was observed
after treatment with Ginkgo biloba extract in a double blind, placebo
controlled study of macular degeneration patients.
24.
Those consuming fish more than once per week were only half as likely
to develop macular degeneration than those consuming it less than
once per month. Those consuming the highest amount of cholesterol
in their diet were 2.7 times more likely to develop advanced macular
degeneration.
25.
Dietary enzymes increase glutathione synthesis which can prevent
free radical-induced apoptosis (cell suicide) and may help prevent
or treat AMD. Progress in Retinal and Eye Research, 2000, Vol. 19,
Iss.2 pp 205-221 (No abstract available)
GLAUCOMA
STUDIES
1.
In a study of open angle glaucoma patients who received 150mg of
Alpha Lipoic Acid each day, 45-47% of the eyes had enhancement of
color visual fields and visual sensitivity when compared to controls
using only topical medical therapy. More advanced cases had an even
better response compared to their controls.
2.
Pretreatment with alpha lipoic acid has been found to reduce neuronal
damage from excitotoxic damage from cyanide, glutamate and iron
ions, demonstrating a strong neuroprotective effect for this substance
in nerve tissue. It may be useful in treating glaucoma.
3.
The eyes of open angle glaucoma patients were found to have significantly
lower vitamin C levels, as well as higher levels of lipic peroxidation
byproducts compared to normals.
4.
Patients suffering from open angle glaucoma and normal-tension glaucoma
who were given magnesium twice daily showed improvement of the visual
field and reduced peripheral vasospasms (which can cause glaucoma,
stroke and heart attack) after four weeks of treatment.
5.
Glaucoma patients treated with vitamin B12 for over 5 years demonstrated
better visual acuity and better overall control of their disease.
Glacome, 1992;
6.
Besides beta carotene, other carotenoids found in dark green leafy
vegetables appear to be much more essential to the health of the
eye. Several studies have shown that lutein and zeaxanthin supplements
may slow vision loss in glaucoma, and in some cases improve eyesight.
Science News, Volume 146.
7.
Anthocyanosides, compounds found in the herb bilberry, were shown
to markedly improve vascular resistance of the capillary wall in
the ciliary body of the eye (the source of excess fluid production).
Boll. Ocul. 65 789-95, 1986
8.
Chronic open angle glaucoma patients had a statistically significant
lower thiamine blood level than controls along with poor absorption
of that nutrient.
9.
Lipoic acid may be useful in the treatment of glaucoma and may help
prevent ischemic optic nerve damage.
10.
The scientific literature supports recommending lipoic acid in complex
with vitamins B1, B2, B5, B6 (pyridoxal phosphate), and vitamin
C to glaucoma patients.
11.
Vascular obstruction and hindrance of the blood flow and impaired
nutrition of neuronal tissue might be the primary causes of glaucoma.
12.
Ginkgo biloba is a potentially important agent in the treatment
of glaucoma. It improves central and peripheral blood flow, reduces
vasospasm, reduces serum viscosity, has antioxidant activity, platelet
activating factor inhibitory activity, and inhibits apoptosis and
excitotoxicity - all factors in preventing glaucoma vision loss.
13.
The fatty acid DHA (abundant in fish oil), along with B Complex
and vitamin E were shown to be helpful in preventing or delaying
vision loss associated with glaucoma.
14.
Ginkgo biloba extract (40mg, three times daily), increased diastolic
blood flow by 23% in the ophthalmic artery in glaucoma patients
and may be helpful in protecting the optic nerve from further damage
and subsequent visual field loss.
15.
Besides alpha lipoic acid, other nutrients which are neuroprotective
include vitamin E, ginkgo biloba, pycnogenol (from grape seed extract
or pine bark), and flavonoids.
DIABETIC
EYE STUDIES
1.
Alpha Lipoic Acid can significantly reduce diabetic cataract formation,
as well as neuropathy, and would seem to be an ideal neuroprotective
substance in the treatment of all oxidative brain and neural disorders
involving free radical processes.
2.
Vitamin E significantly improved glucose tolerance in non-insulin
dependent diabetics, which should very likely result in fewer diabetic
complications.
3.
Diabetic patients with high serum magnesium levels were less likely
to develop severe diabetic retinopathy compared to those with low
levels.
4.
Chromium, high-dose vitamin E, magnesium, soluble fiber, and possibly
taurine appear likely to lessen risk for macrovascular disease (retinopathy)
in diabetics in diabetic patients, significantly reducing the risk
of diabetic retinopathy.
5.
Long term use of multiple antioxidants inhibits the development
of early stage diabetic retinopathy.
6.
Seven of fifteen patients with Type I diabetic retinopathy who were
given vitamin B12 along with their daily insulin injections were
found to have complete regression of retinal signs after 12 months.
Kornerup T, Strom L. Acta Paediatr 1958.
7.
79% of 37 patients with visible diabetic retinal abnormalities improved
after taking 160 mg of bilberry extract twice daily, compared to
0% of the placebo control group, and 86% of those with abnormalities
of angiography findings showed moderate to considerable improvement.
(These improvements were noted within one month.) Perossini, et
al. Ann Ottalmol Clin Ocul 1987.
8.
73% of type I and II diabetics who took chromium supplements reduced
their requirement for insulin or oral hypoglycemic agents. Taking
chromium and niacin together reduced fasting blood sugar levels
and improved glucose tolerance. J Trace Elem Exp Med 1995: 8:183-90;
9.
Low magnesium levels might increase the risk of ischemic heart disease
and severe retinopathy in diabetics, while chromium increases insulin
sensitivity and raises the 'good' HDL cholesterol.
10.
Low serum carotenoid levels were found to be directly related to
an increased risk for developing insulin resistance and diabetes.
11.
Both Panax and American ginseng was shown to normalize glucose tolerance
tests, and reduced blood sugar spikes in Type II diabetics after
consumption of a sugar solution.
12.
In one study all 38 patients with insulin-dependent diabetes were
required to lower their insulin dose to avoid hypoglycemia after
taking 200mg of Gymnema Sylvestre extract twice daily.
RETINITIS
PIGMENTOSA STUDIES
1.
Patients with retinitis pigmentosa appear to have faulty cellular
uptake of the amino acid taurine. Disturbed utilization of vitamin
A also appears to play a part in retinitis pigmentosa, and a subgroup
of patients benefit from supplementation of this vitamin.
2.
The essential fatty acids alpha-linolenic acid and DHA may be required
for those with retinitis pigmentosa to support normal functional
development of the retina.
3.
A diet high in polyunsaturated fats (e.g. corn oil), and low in
vitamin E, selenium, sulfur-containing amino acids (e.g. taurine,
methionine), and chromium were related to a build up of pigment
which mimics one type of retinitis pigmentosa.
4.
Lutein supplementation in high doses improved both visual acuities
and visual fields after 2-4 weeks of treatment in 16 subjects, and
was especially effective in blue eyed individuals.
5.
Vitamin B3 may be a potential therapeutic agent for the treatment
of retinal degeneration, including retinitis pigmentosa.
(c) Copyright 2003 Eye Health Products
|